Prognostic Significance of Exposure to Intermediate-Dose Methotrexate in Children with Standard Risk ALL: The COALL 82/85 Experience
Author:
Publisher
Springer Berlin Heidelberg
Link
http://link.springer.com/content/pdf/10.1007/978-3-642-76591-9_54.pdf
Reference12 articles.
1. Freeman AI, Brecher ML, Wang JJ, Sinks LF (1979) Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia (ALL). Hämatol Bluttransfus 23: 115–123
2. Moe PJ, Seip M, Finne PH (1981) Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Preliminary results of a national treatment program. Acta Paediatr Scand 70: 73–79
3. Janka GE, Mack R, Helmig M, Haas R, Bidlingmaier F (1984) Prolonged methotrexate infusions in children with acute leukemia in relapse and in remission and with medulloblastoma. Pharmacokinetics, toxicity and clinical results. Oncology 41: 225–232
4. Jürgens H (1983) Hochdosierte Methotrexatbehandlung. Indikation, Risiken, Steuerung. Urban and Schwarzenberg, Munich
5. Evans WE, Stewart CF, Chen CH et al. (1984) Methotrexate systemic clearance influences probability of relapse in children with standard risk acute lymphoblastic leukemia. Lancet ß: 359–362
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Daunorubicin during delayed intensification decreases the incidence of infectious complications – a randomized comparison in trial CoALL 08-09;Leukemia & Lymphoma;2018-07-03
2. Cooperative study group for childhood acute lymphoblastic leukaemia (COALL): long-term results of trials 82,85,89,92 and 97;Leukemia;2009-12-17
3. Mechanisms of Treatment Failure in Childhood Acute Lymphoblastic Leukemia: Children’s Cancer Group Initiatives;Acute Leukemias VI;1997
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3